Search research articles
Contact Us
Filters
Showing results (181-190 of 533) with videos related to
Page
of 54
Sort By:
Journal of Alzheimer'S Disease : JAD
|
June 30, 2025
Harnessing greater statistical power: Comprehensive evaluation of disease modifying treatment effects across all or multiple post-baseline visits compared to the last visit for Alzheimer's disease clinical trials
Guoqiao Wang, Tianle Chen, John O'Gorman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Jorge J Llibre-Guerra, Jin Zhou, Lon S S Schneider, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Jin Zhou, Erica Andreozzi, Jorge J Llibre-Guerra, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
September 14, 2019
Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease
Guoqiao Wang, Andrew J Aschenbrenner, Yan Li, et al.
Brain Communications
|
April 13, 2022
A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer's disease
Melissa M Budelier, Yingxin He, Nicolas R Barthelemy, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 24, 2010
Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage
E R Zanier, D Refai, G J Zipfel, et al.
British Medical Journal
|
January 20, 1973
Management of adult acute myelogenous leukaemia
D Crowther, R L Powles, C J Bateman, et al.
Science Translational Medicine
|
December 16, 2016
Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury
Marc Suárez-Calvet, Miguel Ángel Araque Caballero, Gernot Kleinberger, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
January 16, 2022
Interactions Between Weight Loss and Plasma Neurodegenerative Markers for Determining Cognitive Decline Among Community-Dwelling Older Adults
Kelly Virecoulon Giudici, Sophie Guyonnet, John E Morley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 13, 2024
The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence
Paul Aisen, Randall J Bateman, Damian Crowther, et al.
Page
of 54
Search research articles
Search
Showing results (181-190 of 533) with videos related to
Sort By:
Page
of 54
Journal of Alzheimer'S Disease : JAD
|
June 30, 2025
Harnessing greater statistical power: Comprehensive evaluation of disease modifying treatment effects across all or multiple post-baseline visits compared to the last visit for Alzheimer's disease clinical trials
Guoqiao Wang, Tianle Chen, John O'Gorman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Jorge J Llibre-Guerra, Jin Zhou, Lon S S Schneider, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Jin Zhou, Erica Andreozzi, Jorge J Llibre-Guerra, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
September 14, 2019
Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease
Guoqiao Wang, Andrew J Aschenbrenner, Yan Li, et al.
Brain Communications
|
April 13, 2022
A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer's disease
Melissa M Budelier, Yingxin He, Nicolas R Barthelemy, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 24, 2010
Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage
E R Zanier, D Refai, G J Zipfel, et al.
British Medical Journal
|
January 20, 1973
Management of adult acute myelogenous leukaemia
D Crowther, R L Powles, C J Bateman, et al.
Science Translational Medicine
|
December 16, 2016
Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury
Marc Suárez-Calvet, Miguel Ángel Araque Caballero, Gernot Kleinberger, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
January 16, 2022
Interactions Between Weight Loss and Plasma Neurodegenerative Markers for Determining Cognitive Decline Among Community-Dwelling Older Adults
Kelly Virecoulon Giudici, Sophie Guyonnet, John E Morley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 13, 2024
The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence
Paul Aisen, Randall J Bateman, Damian Crowther, et al.
Page
of 54